Literature DB >> 8398692

Bromodeoxyuridine-labelled apoptosis after treatment with antimetabolites in two murine tumours and in small intestinal crypts.

C E Sarraf1, T W Ansari, P Conway, M Notay, S Hill, M R Alison.   

Abstract

Antimetabolites are S-phase specific anticancer drugs. Administration of bromodeoxyuridine (BrdUrd) to tumour bearing mice was followed by treatment with cytosine arabinoside or hydroxyurea. Anti-BrdUrd immunocytochemistry visualised susceptible tumour and intestinal crypt cells at electron microscope level, showing unequivocally that cells that were in S-phase at the time of administration of the drugs subsequently died by apoptosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398692      PMCID: PMC1968621          DOI: 10.1038/bjc.1993.408

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Extreme sensitivity of some intestinal crypt cells to X and gamma irradiation.

Authors:  C S Potten
Journal:  Nature       Date:  1977-10-06       Impact factor: 49.962

Review 2.  Prostate cancer. Growth kinetics.

Authors:  M R Alison; N A Wright
Journal:  Recent Results Cancer Res       Date:  1981

3.  Proportions of mitotic and apoptotic cells in a range of untreated experimental tumours.

Authors:  C E Sarraf; I D Bowen
Journal:  Cell Tissue Kinet       Date:  1988-01

4.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

Authors:  N Itoh; S Yonehara; A Ishii; M Yonehara; S Mizushima; M Sameshima; A Hase; Y Seto; S Nagata
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

5.  Do cells of continually renewing populations and those stimulated from quiescence respond similarly to HU and Ara-C?

Authors:  H P Benton; M R Alison
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

6.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

7.  The nature of cytotoxic drug-induced cell death in murine intestinal crypts.

Authors:  T V Anilkumar; C E Sarraf; T Hunt; M R Alison
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

8.  Kinetic studies on a murine sarcoma and an analysis of apoptosis.

Authors:  C E Sarraf; I D Bowen
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

9.  Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents.

Authors:  K Ijiri; C S Potten
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640

Review 10.  Apoptosis: a gene-directed programme of cell death.

Authors:  M R Alison; C E Sarraf
Journal:  J R Coll Physicians Lond       Date:  1992-01
View more
  4 in total

Review 1.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

Review 2.  Apoptosis Detection Methods in Diagnosis of Cancer and Their Potential Role in Treatment: Advantages and Disadvantages: a Review.

Authors:  Amir Khodavirdipour; Motahareh Piri; Sarvin Jabbari; Shiva Keshavarzi; Reza Safaralizadeh; Mohammad Yousef Alikhani
Journal:  J Gastrointest Cancer       Date:  2021-01-04

3.  Altered spatial learning, cortical plasticity and hippocampal anatomy in a neurodevelopmental model of schizophrenia-related endophenotypes.

Authors:  P Leon Brown; Paul D Shepard; Greg I Elmer; Sara Stockman; Rebecca McFarland; Cheryl L Mayo; Jean Lud Cadet; Irina N Krasnova; Martin Greenwald; Carrie Schoonover; Michael W Vogel
Journal:  Eur J Neurosci       Date:  2012-07-05       Impact factor: 3.386

4.  Altered prepulse inhibition in rats treated prenatally with the antimitotic Ara-C: an animal model for sensorimotor gating deficits in schizophrenia.

Authors:  G I Elmer; J Sydnor; H Guard; E Hercher; M W Vogel
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.